2012
DOI: 10.1371/journal.pone.0051954
|View full text |Cite
|
Sign up to set email alerts
|

Novel Genetic Loci Identified for the Pathophysiology of Childhood Obesity in the Hispanic Population

Abstract: Genetic variants responsible for susceptibility to obesity and its comorbidities among Hispanic children have not been identified. The VIVA LA FAMILIA Study was designed to genetically map childhood obesity and associated biological processes in the Hispanic population. A genome-wide association study (GWAS) entailed genotyping 1.1 million single nucleotide polymorphisms (SNPs) using the Illumina Infinium technology in 815 children. Measured genotype analysis was performed between genetic markers and obesity-r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
304
0
3

Year Published

2014
2014
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 356 publications
(328 citation statements)
references
References 57 publications
11
304
0
3
Order By: Relevance
“…The KLHL29 locus is highly complex and seems to encode multiple proteins containing BTB and kelch motifs but with poorly annotated functions. NAT2 was significant for the joint CVD+T2D end point in our study and was previously detected as a GWAS signal for several important cardiometabolic traits including total cholesterol, triglyceride, 31 and insulin sensitivity (GENESIS consortium, personal communication) that are relevant for both CVD and T2D. NAT2 (N-acetyltransferase 2) is a well-known pharmacogenetic gene responsible for O-and N-acetylation of arylamine and hydrazine drugs and carcinogens but the mechanisms linking NAT2 to cardiometabolic traits are unknown.…”
Section: Discussionsupporting
confidence: 65%
“…The KLHL29 locus is highly complex and seems to encode multiple proteins containing BTB and kelch motifs but with poorly annotated functions. NAT2 was significant for the joint CVD+T2D end point in our study and was previously detected as a GWAS signal for several important cardiometabolic traits including total cholesterol, triglyceride, 31 and insulin sensitivity (GENESIS consortium, personal communication) that are relevant for both CVD and T2D. NAT2 (N-acetyltransferase 2) is a well-known pharmacogenetic gene responsible for O-and N-acetylation of arylamine and hydrazine drugs and carcinogens but the mechanisms linking NAT2 to cardiometabolic traits are unknown.…”
Section: Discussionsupporting
confidence: 65%
“…The nine GWAS SNPs that have giSNPs in the 1,000 genomes dataset were reported in a total of four separate GWAS (Do et al, 2011;Comuzzie et al, 2012;Demirkan et al, 2012;Seppala et al, 2014). In most cases, the SNP did not have a highly significant p-value, and was often reported as suggestive.…”
Section: Genetically Indistinguishable Snps In Humansmentioning
confidence: 99%
“…FAM110A synthesizes a protein that participates in the cell cycle progression, whose role is related to the formation of the centrosome/spindle pole fibers during mitosis (Hauge et al, 2007). In a GWAS in humans, this gene was associated with body measures (waist height) (Comuzzie et al, 2012). SNPs in the gene are associated with growth traits in both species.…”
Section: Chromosomementioning
confidence: 99%